阿布西西马布作为急性ST段升高心肌梗塞的再注血辅助疗法:随机试验的元分析
Giuseppe De Luca1, Harry Suryapranata, Gregg W Stone
1Isala Klinieken, Hospital De Weezenlanden, Zwolle, The Netherlands.
JAMA
|April 14, 2005
概括
在接受初级血管造形手术的ST段升高心肌梗塞 (STEMI) 患者中,abciximab显著降低了死亡率和复发性心脏病发作. 然而,当与纤维素分解相结合时,它会增加出血风险.
科学领域:
- 心脏病学 心脏病学
- 临床试验 临床试验
- 药理学 药理学是指药理学的学科.
背景情况:
- 在ST段升高心肌梗塞 (STEMI) 中abciximab的临床益处仍在争论中.
- 需要综合证据来澄清其在STEMI管理中的有效性和安全性.
研究的目的:
- 对所有评估abciximab在STEMI患者中的随机试验进行元分析.
- 评估阿布西西马布对死亡率,心脏复发和出血并发症的影响.
主要方法:
- 在MEDLINE和PubMed数据库中进行系统搜索 (1990-2004).
- 包括所有已完成,已发表的STEMI随机试验.
- 提取关于研究设计,干预措施,患者特征和临床结果的数据.
主要成果:
- 分析了11项涉及27,115名患者的试验.
- 阿布西西马布减少了初级血管造形术患者的短期 (30天) 和长期死亡率 (P=.047和P=.01,分别).
- 在所有治疗组中,30天内心脏病复发的显著减少 (P<.001).
- 观察到阿布西西马布与纤维素分解 (P<.001) 结合的较大出血风险增加 (P<.001).
结论:
- 在STEMI中辅助abciximab治疗显著降低了初级血管形成术患者的死亡率.
- 阿布西西马布有效地降低了不论再输血策略的复发率.
- 当使用abciximab与纤维素分解时,需要仔细考虑出血风险.
相关概念视频
01:30Acute Coronary Syndrome I: Introduction
2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
961
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
961
01:30Acute Coronary Syndrome III: Diagnostic Studies
502
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
502
01:28Acute Coronary Syndrome IV: Interprofessional Care
528
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
528